Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
- PMID: 8256857
- PMCID: PMC1887265
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
Abstract
Advanced glycation end products (AGEs), the final products of nonenzymatic glycation and oxidation of proteins, are found in the plasma and accumulate in the tissues during aging and at an accelerated rate in diabetes. A novel integral membrane protein, termed receptor for AGE (RAGE), forms a central part of the cell surface binding site for AGEs. Using monospecific, polyclonal antibody raised to human recombinant and bovine RAGE, immunostaining of bovine tissues showed RAGE in the vasculature, endothelium, and smooth muscle cells and in mononuclear cells in the tissues. Consistent with these data, RAGE antigen and mRNA were identified in cultured bovine endothelium, vascular smooth muscle, and monocyte-derived macrophages. RAGE antigen was also visualized in bovine cardiac myocytes as well as in cultures of neonatal rat cardiac myocytes and in neural tissue where motor neurons, peripheral nerves, and a population of cortical neurons were positive. In situ hybridization confirmed the presence of RAGE mRNA in the tissues, and studies with rat PC12 pheochromocytes indicated that they provide a neuronal-related cell culture model for examining RAGE expression. Pathological studies of human atherosclerotic plaques showed infiltration of RAGE-expressing cells in the expanded intima. These results indicate that RAGE is present in multiple tissues and suggest the potential relevance of AGE-RAGE interactions for modulating properties of the vasculature as well as neural and cardiac function, prominent areas of involvement in diabetes and in the normal aging process.
Similar articles
-
Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.Am J Pathol. 1995 Mar;146(3):688-94. Am J Pathol. 1995. PMID: 7887450 Free PMC article.
-
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.J Biol Chem. 1995 Oct 27;270(43):25752-61. doi: 10.1074/jbc.270.43.25752. J Biol Chem. 1995. PMID: 7592757
-
Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.Diabetologia. 2004 May;47(5):844-52. doi: 10.1007/s00125-004-1392-9. Epub 2004 May 1. Diabetologia. 2004. PMID: 15127201
-
RAGE: a novel cellular receptor for advanced glycation end products.Diabetes. 1996 Jul;45 Suppl 3:S77-80. doi: 10.2337/diab.45.3.s77. Diabetes. 1996. PMID: 8674899 Review.
-
Why is CTX all the RAGE?Res Immunol. 1996 May;147(4):261-6. Res Immunol. 1996. PMID: 8844904 Review. No abstract available.
Cited by
-
Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Heart Fail Rev. 2014 Jan;19(1):49-63. doi: 10.1007/s10741-013-9374-y. Heart Fail Rev. 2014. PMID: 23404649 Review.
-
The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation.PLoS One. 2016 Sep 14;11(9):e0161715. doi: 10.1371/journal.pone.0161715. eCollection 2016. PLoS One. 2016. PMID: 27627677 Free PMC article.
-
Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4.J Physiol. 2015 Apr 15;593(8):1873-86. doi: 10.1113/jphysiol.2014.287045. Epub 2015 Feb 27. J Physiol. 2015. PMID: 25640761 Free PMC article.
-
The receptor for advanced glycation end products is a central mediator of asthma pathogenesis.Am J Pathol. 2012 Oct;181(4):1215-25. doi: 10.1016/j.ajpath.2012.06.031. Epub 2012 Aug 11. Am J Pathol. 2012. PMID: 22889845 Free PMC article.
-
Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.Clin Pharmacol Ther. 2015 Aug;98(2):135-44. doi: 10.1002/cpt.148. Epub 2015 Jun 25. Clin Pharmacol Ther. 2015. PMID: 25974754 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources